10-Q: Dynatronics Reports Q2 2025 Results: Sales Decline, Cost-Cutting Measures Implemented Amidst Going Concern Concerns

Dynatronics' Q2 2025 results reveal a decrease in net sales and the implementation of cost-cutting measures to address concerns about the company's ability to continue as a going concern.

Summary

• Dynatronics reported a decrease in net sales for both the three and six months ended December 31, 2024.
• Net sales decreased by 10.4% to $7.3 million for the quarter and by 14.9% to $14.9 million for the six-month period.
• The decline in sales is attributed to reduced volume from OEM customers and lower demand for orthopedic soft bracing products.
• The company experienced a net loss of $775,000 for the quarter and $1.141 million for the six-month period.
• Gross profit decreased by 9.6% to $1.645 million for the quarter and by 12.1% to $3.625 million for the six-month period.
• Selling, general, and administrative expenses decreased by 15.1% to $2.311 million for the quarter and by 13.7% to $4.543 million for the six-month period.
• Management is implementing cost-cutting measures, including eliminating non-essential positions and optimizing square footage, to address concerns about the company's ability to continue as a going concern.
• These measures are expected to reduce expenses by approximately $400,000 for fiscal year 2025 and $1 million on an annualized basis.
• Optimization of square footage could yield additional cost savings of approximately $600,000 annually.
• The company's working capital decreased from $2.853 million as of June 30, 2024, to $1.890 million as of December 31, 2024.
• As of December 31, 2024, the company had $791,000 in cash and cash equivalents.
• The company's line of credit balance was $2.355 million as of December 31, 2024.
• The company entered into a sublease agreement with Ninety Nine Technologies LLC on January 28, 2025, extending through December 31, 2025, with a monthly rent of $19,700.

Sentiment

Score: 4

Explanation: The sentiment is negative due to declining sales, net losses, and concerns about the company's ability to continue as a going concern. However, cost-cutting measures and a slight increase in cash provide a glimmer of hope.

Positives

• Selling, general, and administrative expenses decreased by 15.1% for the quarter and 13.7% for the six-month period.
• Net loss decreased by $236,000 for the quarter and $201,000 for the six-month period.
• The company is actively implementing cost-cutting measures to improve financial performance.
• Cash and cash equivalents and restricted cash increased by $307,000 since June 30, 2024.

Negatives

• Net sales decreased by 10.4% for the quarter and 14.9% for the six-month period.
• The company experienced a net loss of $775,000 for the quarter and $1.141 million for the six-month period.
• Working capital decreased from $2.853 million to $1.890 million.
• The company's auditors have raised substantial doubt regarding the company's ability to continue as a going concern.

Risks

• The company's ability to continue as a going concern is uncertain.
• The company's reliance on its line of credit for financing operations poses a risk.
• Uncertainties in the broader economic environment could adversely affect the company's liquidity and cash flow.
• The company operates in a rapidly evolving and unpredictable business environment.
• The company may be required to raise additional funds through the sale of equity or debt securities or from credit facilities, which may not be available on satisfactory terms, or at all.

Future Outlook

Management forecasts that the Company will have sufficient liquidity to meet its obligations for the next twelve months from the date of the financial statements' issuance due to cost-control initiatives.

Management Comments

• Management is implementing plans to continue the Company as a going concern and believes that by focusing on cost-control initiatives the Company can continue as a going concern.
• Management forecasts that the Company will have sufficient liquidity to meet its obligations for the next twelve months from the date of the financial statements' issuance.

Industry Context

The decrease in sales may reflect broader trends in the medical device industry, such as changes in demand for specific product categories or increased competition.

Comparison to Industry Standards

• It is difficult to compare Dynatronics' results directly to industry standards without knowing the specific segments in which its competitors operate and their financial performance.
• Comparable companies in the medical device space include DJO Global, Enovis, and Zimmer Biomet, but their product portfolios and market focus may differ significantly.
• Dynatronics' gross profit margin of 24.3% for the six months ended December 31, 2024, can be compared to the gross profit margins of its competitors to assess its relative profitability.
• However, a more detailed analysis of Dynatronics' specific product categories and customer base is needed to draw meaningful conclusions.

Related Party Transactions

• The Company leases office, manufacturing and warehouse facilities in Northvale, New Jersey, and Eagan, Minnesota from shareholders and entities controlled by shareholders who were previously principals of businesses acquired by the Company.
• The combined expenses associated with these related-party transactions totaled $347,687 and $332,989 for the three months ended December 31, 2024 and 2023, respectively, and $684,912 and $666,938 for the six months ended December 31, 2024 and 2023, respectively.

Stakeholder Impact

• Shareholders may be concerned about the declining sales, net losses, and going concern uncertainty.
• Employees may be affected by cost-cutting measures, including the elimination of non-essential positions.
• Customers may be impacted by changes in product availability or pricing.
• Suppliers may be affected by changes in the company's purchasing patterns.
• Creditors may be concerned about the company's ability to repay its debts.

Next Steps

• Continue implementing cost-cutting measures.
• Optimize square footage for both business segments.
• Reduce excess inventory exposure.
• Monitor liquidity and cash flow closely.
• Evaluate the need for additional financing.

Key Dates